ABSTRACT OBJECTIVES This study sought to investigate long-term clinical outcomes following coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) in patients with unprotected left main disease (ULMD).
U nprotected left main disease (ULMD) occurs in 5% to 7% of patients undergoing coronary angiography and its 3-year mortality without revascularization is 50% (1) . Coronary artery bypass graft (CABG) surgery has been recommended as the standard treatment for patients with ULMD (2) . However, with advances in interventional cardiology, percutaneous coronary intervention (PCI) has been increasingly used for ULMD, and outcomes of ULMD PCI have significantly improved over time (3) (4) (5) (6) . Figure 1) . ULMD is defined as left main artery luminal narrowing of more than 50% without patent bypass grafts to its branches (14) . Patients were excluded if they were younger than 18 years of age, or had prior CABG, concomitant valvular, or aortic surgery, ST-segment elevation myocardial infarction (MI) within 1 week, or cardiogenic shock. The SYNTAX score algorithm was not available at the beginning of the study period. A retrospective review of a baseline angiogram for calculation of the SYNTAX score in the standard fashion by using the web-based score calculator (www.syntaxscore.com) (15, 16) at an angiographic core lab was available in 2,752 patients (68.0% of the total study population).
The decision to perform CABG or PCI was made by cardiologists and surgeons, taking into account the available clinical and anatomic factors as well as patient's preference (Online Table 1 ). Patients underwent CABG or PCI, because of either the risk associated with each revascularization procedure or the patient's or physician's preference (Online Figure 2 ). An anesthetic protocol was followed, and surgical revascularization was performed using standard bypass techniques (Online Appendix) (17) . CABG procedures were performed with cardiopulmonary bypass or off-pump, at the surgeon's discretion.
Whenever possible, complete revascularization using arterial grafts was recommended. Antiplatelet therapy consisting of aspirin 100 mg/day was continued indefinitely post-operatively (17) .
For the PCI group, consecutive patients with ULMD who underwent drug-eluting stents implantation were included. All patients undergoing PCI were prescribed aspirin plus clopidogrel (loading dose, 300 or 600 mg) before the coronary intervention (18) .
Lesions in the ostium or body of the ULM usually received a single stent and post-dilation with kissing balloon angioplasty was always used to finish the procedure when treating distal ULM bifurcation with 2-stent technique (16) . Use of intravascular ultrasound, adjunctive devices, or glycoprotein IIb/IIIa inhibitors was at the operator's discretion (Online Appendix). The use of dual antiplatelet therapy with aspirin and clopidogrel was recommended for at least 12 months after stent implantation (18) .
Other pharmacological treatments including angiotensin-converting enzyme inhibitors, betablockers, and statins, were recommended on the basis of current practice in both treatment groups (17) (18) (19) . OUTCOMES. The standard institutional follow-up procedures have been described previously (20, 21) .
Briefly, all patients discharged alive were required to return for a routine outpatient follow-up at 1 month, 6 months, and then each year after discharge.
Research nurses contacted patients who did not return for follow-up visit by either telephone or mail.
The primary outcome measure was 3-year all-cause mortality after the initial revascularization. The secondary outcome was a composite of death, nonfatal MI, or nonfatal stroke. In addition, any repeat revascularization after the initial procedure was evaluated as well. Specific definitions of the outcome components are listed in the Online Appendix, and all occurrences of the outcomes were adjudicated independently by an events committee. Table 3 ). The risk-adjusted odds ratios for 30-day outcomes were calculated with the use of the inverse probability weighting approach (24) . For comparisons of longterm outcomes between 2 treatment groups, we used adjusted survival curves and weighted Cox proportional hazards regression with inverse probabilityof-treatment weighting to determine hazard ratios (HRs) (Online Table 4 ) (24) . To further assess the robustness of our findings, additional sensitivity analyses were conducted. We evaluated the outcomes between the CABG and PCI groups in those with complete baseline SYNTAX scores and in selected patients without any potential contraindications to CABG. 33.3 AE 7.8; p < 0.001) ( Table 1 ). The procedural characteristics are shown in Table 2 . After inverse probability weighting adjustment, all the clinical covariates were well balanced (Online Table 5 ).
PRIMARY AND SECONDARY OUTCOMES. The unadjusted 30-day all-cause mortality was higher in the PCI group than in the CABG group (0.8% vs. 0.3%; p ¼ 0.03) (Online Table 6 ). After adjustment using inverse-probability-weighting approach, PCI was associated with an increased risk of 30-day mortality (adjusted odds ratio: 5.30; 95% confidence interval [CI]: 2.83 to 9.94; p < 0.001) and composite outcome of death, nonfatal MI, or nonfatal stroke (odds ratio:
2.14; 95% CI: 1.70 to 2.70; p < 0.001).
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At 3 years after the procedure, Kaplan-Meier estimates of all-cause mortality were 3.8% in the PCI group and 2.5% in the CABG group (Table 3, Figure 1 ).
After adjustment, the 3-year risks were significantly higher in the PCI group for all-cause death (HR: 
DISCUSSION
In this large study of ULMD, we found that both CABG and PCI yield satisfactory long-term outcomes.
Although patients undergoing CABG had an increased risk of stroke, the overall benefits in terms of all-cause death, cardiac death, myocardial infarction, and repeat revascularization were found in patients treated with CABG compared with those treated with PCI. These results were consistent among patients with high-risk anatomic characteristics. However, for patients with less complex disease (low or intermediate SYNTAX scores), the risk of all-cause death was not significantly different between 2 treatment groups, and the risk of composite cardiac and cerebrovascular events was even lower in the PCI group In the present study, likely due to a considerably greater number of patients with unstable angina, the 30-day mortality in PCI group was statistically higher than in CABG group. Particularly, most available studies with long-term follow-up were underpowered to detect significant differences in mortality or hard end points (7-9,11). Another study by Fortuna et al. (29) in a "real-world" setting also found benefit for CABG in reducing overall 5-year mortality compared with PCI, especially in patients with left main coronary artery disease combined with 2-vessel or 3-vessel coronary artery disease (29) . In this ULMD cohort, the 3-year all-cause mortality was 2.5% in the CABG group and 3.8% in the PCI group. Although the mortality rates in our study are lower than those reported in MAIN-COMPARE (Revascularization for unprotected Left Main Coronary Artery Stenosis:
Comparison of Percutaneous Coronary Angioplasty versus Surgical Revascularization) study (8.3% mortality at 3 years) (9) , and the SYNTAX trial (12.1% mortality at 5 years) (30), the survival differences might be attributed to the younger age and lower-risk profile in our population (16, 21) . Similarly, the PRECOMBAT (Premier of Randomized
Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left
Main Coronary Artery Disease) study from Korea Values are n (%) or hazard ratio (HR) (95% confidence interval [CI]). *Data are Kaplan-Meier estimates of cumulative event rate at 3 years, expressed as percent of patients. †Inverse probability-of-treatment weighted Cox proportional hazards regression was used with adjustment for patient-level variables in Online Table 1 . The HRs were reported for patients undergoing PCI with those undergoing CABG as reference.
Abbreviations as in Table 1 . Values are n, n (%), or mean AE SD.
IABP ¼ intra-aortic balloon pump; IMA ¼ internal mammary artery; IVUS ¼ intravascular ultrasound; LAD ¼ left anterior descending branch; other abbreviations as in Table 1 .
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reported a 2-year mortality rate of 2.4% to 3.4%, and a 5-year mortality rate of 5.7% to 7.9% (31) , showing that there might be a racial or ethnic difference in the propensity for cardiovascular events as the SYNTAX study involved a U.S. and European population.
In our study of 4,046 consecutive patients with ULMD, 2,604 (64.4%) of them received CABG whereas 1,442 (35.6%) patients received PCI (Online Figure 1) .
Moreover, the overall proportion of patients who had angiographically confirmed ULMD at our institution was 23.1% among those receiving CABG and 4.6% among those receiving PCI, which reflected the angiographic and treatment selection profile in the The p values were calculated using the log-rank test on the basis of all available follow-up data. CABG ¼ coronary artery bypass graft; CI ¼ confidence interval; HR ¼ hazard ratio; PCI ¼ percutaneous coronary intervention; MI ¼ myocardial infarction. L . 9 , N O . 1 1 , 2 0 1 6 Furthermore, the results of our study showed that the impact of diabetes mellitus on clinical outcomes among patients treated with PCI was limited, but was more pronounced among those treated with CABG.
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We observed that the cumulative rate of nonfatal stroke was significantly higher in the CABG group A treatment strategy involving a multidisciplinary approach in this high-risk patient group with complex coronary artery lesions is critically important.
When possible, the interventional cardiologist and cardiac surgeon should decide together using a heart term approach on the optimal revascularization modality. Values are n, n (%), or HR (95% confidence interval). *Data are Kaplan-Meier estimates of cumulative event rate at 3 years, expressed as percent of patients. †Inverse probability-of-treatment weighted Cox proportional hazards regression was used with adjustment for patient-level variables in Online Table 1 . The HRs were reported for patients undergoing PCI with those undergoing CABG as reference. Tables 1 and 3 . 
Abbreviations as in

